WDR5 and pancreatic neoplasm: WDR5 has been shown to cooperate with HOTTIP to promote HOXA9 in prostate and pancreatic cancer [43, 44] and HOXA13 expression in esophageal and gastric cancer cells by increasing H3K4Me3 on their promoters [45, 46].